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A B S T R A C T
Background
Testing pregnant women for HIV at the time of labor and delivery is the last opportunity for
prevention of mother-to-child HIV transmission (PMTCT) measures, particularly in settings
where women do not receive adequate antenatal care. However, HIV testing and counseling of
pregnant women in labor is a challenge, especially in resource-constrained settings. In India,
many rural women present for delivery without any prior antenatal care. Those who do get
antenatal care are not always tested for HIV, because of deficiencies in the provision of HIV
testing and counseling services. In this context, we investigated the impact of introducing
round-the-clock, rapid, point-of-care HIV testing and counseling in a busy labor ward at a
tertiary care hospital in rural India.
Methods and Findings
After they provided written informed consent, women admitted to the labor ward of a rural
teaching hospital in India were offered two rapid tests on oral fluid and finger-stick specimens
(OraQuick Rapid HIV-1/HIV-2 tests, OraSure Technologies). Simultaneously, venous blood was
drawn for conventional HIV ELISA testing. Western blot tests were performed for confirmatory
testing if women were positive by both rapid tests and dual ELISA, or where test results were
discordant. Round-the-clock (24 h, 7 d/wk) abbreviated prepartum and extended postpartum
counseling sessions were offered as part of the testing strategy. HIV-positive women were
administered PMTCT interventions. Of 1,252 eligible women (age range 18 y to 38 y)
approached for consent over a 9 mo period in 2006, 1,222 (98%) accepted HIV testing in the
labor ward. Of these, 1,003 (82%) women presented with either no reports or incomplete
reports of prior HIV testing results at the time of admission to the labor ward. Of 1,222 women,
15 were diagnosed as HIV-positive (on the basis of two rapid tests, dual ELISA and Western
blot), yielding a seroprevalence of 1.23% (95% confidence interval [CI] 0.61%–1.8%). Of the 15
HIV test–positive women, four (27%) had presented with reported HIV status, and 11 (73%) new
cases of HIV infection were detected due to rapid testing in the labor room. Thus, 11 HIV-
positive women received PMTCT interventions on account of round-the-clock rapid HIV testing
and counseling in the labor room. While both OraQuick tests (oral and finger-stick) were 100%
specific, one false-negative result was documented (with both oral fluid and finger-stick
specimens). Of the 15 HIV-infected women who delivered, 13 infants were HIV seronegative at
birth and at 1 and 4 mo after delivery; two HIV-positive infants died within a month of delivery.
Conclusions
In a busy rural labor ward setting in India, we demonstrated that it is feasible to introduce a
program of round-the-clock rapid HIV testing, including prepartum and extended postpartum
counseling sessions. Our data suggest that the availability of round-the-clock rapid HIV testing
resulted in successful documentation of HIV serostatus in a large proportion (82%) of rural
women who were unaware of their HIV status when admitted to the labor room. In addition, 11
(73%) of a total of 15 HIV-positive women received PMTCT interventions because of round-the-
clock rapid testing in the labor ward. These findings are relevant for PMTCT programs in
developing countries.
The Editors’ Summary of this article follows the references.
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Introduction
Worldwide, about 18 (45%) of 40 million HIV-infected
individuals are women [1]. The vast majority (60%) of new
HIV infections occur in women of reproductive age and in
infants and children [1]. With only 9% of pregnant women
receiving antiretroviral therapy (ART) (as compared to the
UNAIDS/WHO target of 80%), an urgent scaling up of HIV
prevention efforts are needed to avert a pediatric HIV
epidemic [1]. Controlling HIV infection in women and
children is crucial for changing the trajectory of the global
HIV epidemic.
Standard interventions for prevention of mother-to-child
transmission (PMTCT) can significantly reduce HIV trans-
mission in infants [2]. About 75% of perinatal HIV trans-
mission occurs during labor and delivery [3]. To effectively
administer PMTCT interventions, rapid and timely ascertain-
ment of HIV serostatus is an absolutely critical step. In many
developing countries, women frequently fail to get tested for
HIV early in their pregnancy, leaving health care providers
only a brief time window during labor and delivery in which
to test and intervene. In such urgent situations, rapid, point-
of-care, easy to use HIV tests may be extremely helpful,
especially noninvasive formats such as oral fluid point-of-care
tests [4,5]. For example, in a previous diagnostic study in
India, we had shown that the oral fluid–based OraQuick HIV-
1 & HIV-2 rapid test (OraSure Technologies, http://www.
orasure.com/) was 100% sensitive and 100% specific [4]. Our
recent systematic review of rapid HIV testing found sufficient
evidence on their high accuracy and feasibility in pregnant
women [6].
Worldwide, about one in eight women is deprived of
adequate prenatal care, and one in nine is not tested for HIV
[7]. In 2005, the global coverage of PMTCT interventions was
estimated at only 8% [8]. Lack of knowledge of HIV serostatus
has been identified as a key factor limiting the widespread
implementation of PMTCT programs [8]. To address this
issue, innovative approaches that help increase and improve
acceptability, availability and feasibility of HIV testing and
counseling services are the key to enhancing the implemen-
tation of available PMTCT interventions [8]. With this in
mind, we set out to conduct this study in rural India, where
we aimed to evaluate the impact of introducing rapid HIV
testing in the labor room setting.
In India, according to the HIV Sentinel Surveillance Report
2005, of all estimated adults living with HIV infection, about
38.4% infected were women, and 57% were from rural areas
[9]. Anecdotal reports estimate that nearly half (50%) of rural
Indian women present for any antenatal care for the first
time only during labor and delivery [10]. Hospitals in India
often document these women as ‘‘unbooked’’ or ‘‘unregis-
tered’’ cases. There may be several reasons for women
presenting only at the time of delivery: (1) preference for
home delivery; (2) inadequate access to healthcare services in
rural areas; (3) inadequate antenatal care due to the low
priority for women’s health; (4) poverty; (5) illiteracy [10].
Thus, lack of antenatal care, lack of knowledge of HIV
serostatus coupled with late presentation to the hospitals in
labor (often with obstetric complications) with an insufficient
available time window for HIV testing and intervention can
lead to mother-to-child HIV transmission. In 2005, 3.8% of
HIV transmission (4,755 cases) in infants in India were
attributed to mother-to-child HIV transmission [9]. These
data indicate that testing early in pregnancy may not be
adequate in India, because a significant proportion of women
present only during labor and delivery.
In this context, we set out to investigate in rural pregnant
women in labor in India, the impact of introducing an
innovative round-the-clock (24 h, 7 d a week) oral fluid–
based, rapid HIV testing and counseling program. Our study
objectives were: (1) to determine the prevalence of HIV
infection in women presenting to the labor and delivery ward
with incomplete or no knowledge of HIV serostatus; (2) to
determine the impact of round-the-clock HIV testing in labor
(i.e., detection of new HIV cases among women with no prior
HIV testing, improvement in the uptake of HIV testing,
preference for rapid testing); (3) to determine the feasibility
of abbreviated prepartum and extended postpartum counsel-
ing sessions in a busy labor ward setting.
Methods
Study Setting
Our study was conducted between January and September
2006, in the Department of Obstetrics and Gynecology at the
Mahatma Gandhi Institute of Medical Sciences (MGIMS), a
rural, tertiary-care, teaching hospital in Sevagram, India with
an estimated 3,500 deliveries each year. This hospital serves as
a high-risk obstetric unit to several villages in Wardha district
in central India. The study was jointly approved by the ethics
committees at the University of California, Berkeley, United
States, and the MGIMS hospital, Sevagram, India.
Criteria for Recruitment
To be eligible for recruitment into our study, women had
to be: aged 18–45 y, in active and/or early (incipient) labor
according to the criteria used by attending obstetricians at
the MGIMS hospital, willing to provide informed consent in
the labor ward, and willing to undergo prepartum and
postpartum counseling sessions. Women with unknown,
unreported HIV serostatus and those presenting with poorly
reported and poorly documented HIV test results with
unclear HIV serostatus were also included. Women present-
ing at any gestational age were included.
Women were excluded if they were recipients of ART or
were in poor general medical condition (including obstetric
emergencies) or with severe mental health problems that
precluded informed consent.
Recruitment Process in the Labor Ward
All consecutive women admitted to the labor ward were
identified by the project manager (an attending obstetrician)
and her assistants (residents in training), using the labor ward
register, maintained by the labor ward staff. This was done on
a round-the-clock daily basis. The project manager evaluated
women for eligibility, and those found to be eligible were
approached for written informed consent. Women who
consented were offered prepartum counseling and HIV
testing. At any time, women were given the option to refuse
testing and counseling.
Written Informed Consent
The informed consent form explained the details of the
study, the HIV testing procedure and interventions available
for the patient, in two local languages (i.e., Hindi and
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Marathi). This information was orally communicated to the
women by a trained counselor, in the presence of the project
manager after the patient was admitted in the labor ward. All
women were encouraged to ask questions at any time during
the consenting process.
HIV Counseling Sessions
HIV counseling and testing were both conducted in the
labor ward. Three trained counselors (all women) took turns
in 8 h shifts to make themselves available round-the-clock to
provide 24 h coverage to the labor room. This, however, was
not the case prior to the start of the project. All counselors
were previously trained as part of the Government of India’s
PMTCT program.
Because prior studies had reported significant challenges in
implementing conventional HIV counseling in the labor ward
setting, we decided to conduct counseling in two stages; first,
an abbreviated prepartum counseling session and subse-
quently, an extended postpartum session [11,12]. Prior to
conducting this study, the feasibility of the two-stage
counseling process was assessed in a pilot study on 20 women.
Based on the results of the pilot study and feedback from
participants, the consent process, prepartum counseling, and
postpartum counseling were modified.
Prepartum abbreviated session. In the prepartum abbre-
viated session (10–15 min), key messages conveyed included
modes of transmission of HIV, importance and benefits of
HIV testing, information on PMTCT, and interventions
available for PMTCT. Flip charts and materials provided by
the Government of India’s National AIDS Control Organ-
ization (NACO) were used at all times for counseling.
Questions and concerns regarding delivery of interventions
and test procedures were addressed at the time of counseling.
Information was conveyed in one of two local languages,
Hindi or Marathi, depending on the preference of the
patient. In general, prepartum counseling sessions were done
in private, unless the women asked for the presence of family
member(s). As far as it was possible in this busy labor ward,
privacy was ensured by using screens/curtains to cover the
area around the bed. In women who were in active labor,
counseling was conducted between contractions.
During prepartum counseling sessions, women were
provided with the option of knowing their result immediately
after testing or after delivery during the postpartum
counseling sessions. Thus, test results were reported depend-
ing on the preference of participants. Women were informed
that, if they were found to be HIV-positive, further consent
would be required for interventions to prevent transmission
of HIV to the baby.
Postpartum extended session. Among women diagnosed
with HIV infection, the postpartum session was used to
provide details on what interventions were available, and the
prognosis of treatments administered. This information was
always conveyed in private by an attending obstetrician. No
family member was allowed to be present unless the patient
consented to his/her presence. Among women diagnosed with
HIV, counselors provided additional information on steps to
be taken to prevent further HIV transmission, information
on HIV transmission through breast milk, and avoidance of
mixed feeding. Social support available to the mother for
implementing the recommendations on breast feeding was
assessed. Information on ART and prophylaxis, including
referrals to the nearest free ART center, were provided. The
importance of regular follow-up visits to the hospital for
monitoring was emphasized. The extended postpartum
counseling sessions typically lasted between 30–40 min
among women diagnosed with HIV infection.
Among women who were HIV seronegative, the postpar-
tum counseling sessions lasted about 15 min. In these sessions,
women were counseled on risk reduction strategies by the
counselors, and asked to return for repeat HIV testing in 3
mo when: (1) the couple was serodiscordant, or (2) the woman
presented with a high-risk profile.
Risk factor, demographic, and test preference information
were collected from all women in face-to-face interviews
during prepartum and postpartum counseling sessions. In
extended postpartum counseling sessions, additional infor-
mation on various feeding options (e.g., exclusive breast milk,
formula feed, top feed, mixed feed), time of weaning, and
social support was also collected from seropositive women.
HIV Testing Algorithm
Figure S1 demonstrates the HIV testing algorithm. HIV
testing was performed by trained counselors in the labor
ward. Women were informed that they could refuse testing at
any time. Two rapid OraQuick tests were performed in
parallel, one on oral fluid, and one on finger-stick blood, to
ascertain HIV serostatus. Both tests have been validated in
India previously [4], and were performed according to
manufacturer’s instructions, including use of external con-
trols [13]. Although the oral-fluid test was the novel rapid test
that was being evaluated for its convenience and feasibility in
urgent settings, we chose a parallel testing strategy (i.e., two
rapid tests) that is known to improve diagnostic accuracy.
Immediately after the two rapid tests were conducted,
phlebotomy was performed to collect venous blood (5 ml of
blood) for the reference standard tests: single ELISA
(Vironostika HIV Uniform II Ag/Ab Plus O, Organon
Teknika) alone for rapid test negative participants, and dual
ELISA plus Western blot (Qualicode HIV1/2 Kit, Immunetics)
for rapid test positive participants. As a quality control
measure, all ELISA and Western blot positive samples were
independently confirmed by an external reference laboratory
(with 100% concordance) at regular intervals by sending
random samples every month.
HIV seropositivity was diagnosed only when oral and
finger-stick OraQuick tests were both reactive, and sub-
sequently confirmed by dual ELISA and Western blot.
However, for immediately decision making in the labor ward,
a positive result by both oral fluid and finger-stick OraQuick
was considered adequate, even if this meant potentially over-
treating some participants. Women were considered HIV
seronegative when both oral and finger-stick OraQuick were
nonreactive and were subsequently confirmed negative by a
single ELISA. We resolved any discordant test results (i.e.,
discordant OraQuick rapid tests, or discordance of rapid test
results with ELISA tests) by repeating rapid OraQuick rapid
tests, and confirmatory testing (dual ELISA and Western
blot).
The results of the rapid OraQuick tests were available to
the attending obstetricians within 20 min of completion of
rapid testing. However, results of confirmatory tests (i.e.,
ELISA and Western blot) were available within 1–3 d
postdelivery.
PLoS Medicine | www.plosmedicine.org May 2008 | Volume 5 | Issue 5 | e920770
Rapid HIV Testing of Women in Labor
PMTCT Interventions for HIV-Positive Women
HIV-positive women were urgently referred for elective
cesarean section and ART administration if they presented
with unruptured membranes. For an elective cesarean
section, a 3–4 h time window was required to deliver
interventions and also allow ART drugs to attain peak levels
in the maternal circulation. This time window varied with the
patient’s medical condition and stage of labor. For vaginal
delivery, however, ART drugs were administered in estab-
lished labor in the first stage.
The HIV-positive women who presented with ruptured
membranes were administered ART and were delivered
vaginally, if they did not consent to an emergent cesarean
section. This decision was left to the women. In such cases, an
elective cesarean section was not offered as its advantage was
lost. In contrast, for all obstetric indications, an emergent
cesarean section was conducted irrespective of HIV seros-
tatus.
All HIV-positive women received standard doses of
Nevirapine, Zidovudine, and Lamivudine at the time of labor
(intrapartum), followed by Zidovudine and Lamivudine for
one wk post delivery (postpartum) [14–17]. Infants received
single dose Nevirapine and Zidovudine for one wk [17]. Infant
HIV serostatus was assessed using HIV DNA polymerase chain
reaction (PCR) within 48 h of delivery and at one mo and four
mo after delivery. Infants are currently being followed for
confirmatory HIV testing at 18 mo.
At time of discharge from the hospital, mothers were
referred for free ART at the nearest government-supported
ART center. Additionally, prophylaxis, and continuity of care
was done at the Internal Medicine department of the MGIMS
hospital. HIV infected infants were referred to the Pediatrics
department of the MGIMS hospital for care and follow up.
Sample Size and Data Analysis
Based on previous Indian studies and clinical experience at
the study site, we a priori anticipated an overall HIV
prevalence of 1.5% among women admitted to the labor
ward at the MGIMS hospital. [10,11] To estimate this
prevalence with a precision of about 0.5%, we planned to
enroll 1,500 eligible women. However, because of lower than
anticipated enrollment, we completed the study with a total
sample size of 1,222.
Data were analyzed using Stata (Version 9.0, Stata Corp,
http://www.statacorp.com/). Outcomes of the study included
HIV seroprevalence, diagnostic accuracy of rapid tests, client
preference for rapid tests, proportion of women whose HIV
status was documented because of labor ward testing,
proportion of new HIV cases that were picked up because
of labor ward testing, and proportion of HIV-positive women
who received PMTCT interventions because of labor ward
testing. HIV seroprevalence was calculated along with 95%
confidence intervals (CIs). Diagnostic accuracy was evaluated
using sensitivity (true-positive rate) and specificity (false-
positive rate), with 95% CI estimates. Agreement between test
results was assessed using the kappa statistic.
Results
Description of Study Participants
Figure 1 demonstrates the flow of participants in the study.
During the study period, of 1,252 eligible women approached
for informed consent and participation in the study, 1,222
(98%) consented to testing. Due to round-the-clock avail-
ability of the counselors, none of the eligible women were
missed. However, women with mental health problems and
obstetric emergencies were excluded at the outset. Eligible
women who refused testing (n ¼ 30) either perceived
themselves to be not at risk, or claimed to have been tested
in the past, and were confident that they were not HIV
infected. Thus, excluding refusals, a total of 1,222 participants
underwent rapid testing in the labor ward between January
2006 and September 2006.
The demographic and risk profile characteristics of the
study participants, stratified by HIV serostatus, are shown in
Table 1. The mean age of seronegative women was 24 y (range
18–38 y) and that of seropositive women was 22 y (range 20–
28 y). About 79% of seronegative and 80% of seropositive
women were educated up to high school. About 71% of
seronegative and 93% of seropositive women were house-
wives. A majority of women were from low socioeconomic
strata; the total monthly income per household was below Rs
(Rupees) 5,000 (approximately US$125) for 90% of sero-
negative and 86% of seropositive women.
Overall, about 99% of all study participants were married,
monogamous, with less than 1% reported having engaged in
sex outside marriage. About 5% of the participants reported
that their husband used drugs and alcohol before sex. About
2% of the women reported have had blood transfusions in
Figure 1. Flow of Participants Through the Study
doi:10.1371/journal.pmed.0050092.g001
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the past. A vast majority (84%) of the women reported no
symptoms of sexually transmitted diseases. Only about 2% of
the women reported that their spouse/partner had been
tested for HIV and only 1% reported that their spouse was
HIV-positive.
Results of HIV Testing
Of 1,222 study participants, 563 (46%) presented with some
history of HIV testing during pregnancy. The remaining 659
participants (54%) were never tested during their pregnancy.
Of 563 women who had claimed to have been tested, 367
(65%) reported being tested in private health facilities, 46
(8%) in government facilities, and 15 (3%) in nongovernment
organizations, while the rest (24%) could not recall the site of
testing.
Of 563 women, 327 (58%) were unaware of the results of
the HIV test result, due to either failure in picking up test
results or not receiving a report of HIV test from private
facilities. The remaining participants, 3% (17/563) were
unwilling to disclose the test result. About 39% (219/563) of
the participants claimed to know the result, but their
documentation of test result was of poor quality, perhaps
due to the fact that many were tested in private settings,
including unlicensed health professionals.
Of the 1,222 women who participated in the study, 15
women were found to be HIV-positive using the reference
standard of dual ELISA and Western blot. Thus, the overall
HIV seroprevalence rate during the study period was 1.23%
(95% CI 0.61%–1.8%)
Overall, of the 1,222 women who underwent testing in the
labor ward, 1,003 (82%; 95% CI 79.8%–84.2%) had never
been HIV tested, or had been tested but were unaware of
their HIV status (Figure 1). Thus, the use of labor room rapid
HIV testing resulted in the ascertainment of information on
HIV serostatus in 82% of all women, who would not have
known their HIV status otherwise. Of the 15 HIV-positive
women, four presented with previously reported HIV test
results. Thus, 11 of 15 HIV infected (73.3%; 95% CI: 47.5%–
90.9%) women were newly diagnosed at point-of-care,
resulting in substantially higher case detection of HIV
positives due to the round-the-clock testing program.
PMTCT Interventions
Of the 15 HIV-positive women, 14 (93.3%; 95% CI 71.3%–
99.7%) received PMTCT interventions, both in the intra-
partum and postpartum period. Only one HIV-positive
woman was found nonreactive with both OraQuick rapid
tests, but she was later found positive by ELISA (and
confirmed by Western blot). This participant and the infant
did not receive intrapartum interventions, but were admin-
istered ART postpartum, within 24 h of receiving the positive
test results.
Of the 15 infants delivered by HIV-infected women, two
infants were HIV DNA PCR positive within 48 h. Of these,
Table 1. Demographic and Risk Factors in HIV Seronegative Women and Seropositive Women
Risk Factors Category Seronegative Women (n ¼ 1,207) Seropositive Women (n ¼ 15)
Marital status (married) — 99% (1196/1207) 100% (15/15)
Age (mean and range) — 24 (18–38 y) 22 (20–28 y)
Education Illiterate 2.5% (30/1,207) 6.7% (1/15)
Primary School 5.3% (64/1,207) 6.7% (1/15)
Middle School 30.5% (368/1,207) 26.7% (4/15)
High School 43.5% (525/1,207) 47% (7/15)
Diploma/Bachelor 16.5% (199/1,207) 13%(2/15)
Professional 1.8% (21/1,207) 0%(0/15)
Monthly household income Rs 1–1,000 11% (138/1,207) 6.7% (1/15)
Rs 1,001–3,000 53% (636/1,207) 67% (10/15)
Rs 3,001–5,000 26% (314/1,207) 13%(2/15)
Rs 5,001–10,000 8% (98/1,207) 13% (2/15)
Rs 10,001–25,000 1.5% (18/1,207) 0% (0/15)
Rs 25,001–above 0.25% (3/1,207) 0% (0/15)
Occupation (self) Laborer /factory/field worker 12% (146/1,207) 7% (1/15)
Farmer 14% ( 172/1,207) 0% (0/15)
Housewife 71% (852/1,207) 93% (14/15)
Business 0.4% (5/1,207) 0% (0/15)
Teacher 0.91% (11/1,207) 0% (0/15)
Student 0.08% (1/1,207) 0% (0/15)
Other 1.7% (20/1,207) 0% (0/15)
Current STD symptoms No symptoms 84% (1,014/1,207) 40% (6/15)
Vaginal discharge 9% (1,13/1,027) 47% (7/15)
Burning during urination 6% (77/1,027) 13% (2/15)
Genital ulcer 0.25% (3/1,027) 0% (0/15)
Condom use — 95% (1,145/1207) 80% (12/15)
Past blood transfusion — 2% (23/1207) 13% (2/15)
Previous HIV testing — 31% (379/1,207) 27% (4/15)
Spouse with TB — 1.2% (14/1,207) 27% (4/15)
Lifetime number of sexual partners One 99.5% (1,201/1,207) 67% (10/15)
Two 0.5% (6/1,207) 27% (4/15)
Three 0% (0/1,207) 7% (1/15)
doi:10.1371/journal.pmed.0050092.t001
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one infant died within 1 wk, and the other died within 1 mo
of delivery. The remaining 13 infants were HIV DNA PCR
negative at 48 h, 1 mo and 4 mo after delivery.
Turn Around Times for Testing and Interventions
The time interval between eligibility assessment and
informed consent was 5–10 min. The time taken for pretest
counseling on average was 15 min, and time taken for HIV
rapid testing on average was 20 min. In sum, the total time
from eligibility assessment of the study participant to referral
for PMTCT intervention averaged 40–60 min.
Diagnostic Accuracy of Rapid HIV Tests
Both oral fluid and finger-stick OraQuick rapid tests had
similar diagnostic accuracy (Tables 2 and 3). The sensitivity of
both tests was 93.3% (95% CI 71.3–99.7%) and specificity was
100% (95% CI 99.75–100%). One negative OraQuick rapid
HIV test result (by both oral and finger-stick OraQuick) was
later found to be positive by the reference standard of ELISA
and Western blot. Thus, the false negative rate was 6.7%.
Agreement between the oral fluid and finger-stick OraQuick
results was perfect (kappa ¼ 1.00). There were no discordant
OraQuick rapid test results.
Client Preference for Rapid Testing
Client preference for rapid testing was assessed during the
postpartum counseling. When asked which HIV test partic-
ipants would prefer for first time and repeat testing, most
participants (70%) reported that the oral fluid–based
OraQuick would be their preferred choice. When questioned
as to which test would they recommend a friend for testing,
74% participants preferred oral fluid testing, 24% preferred
finger-stick, and 1% preferred the venous blood draw.
Minimum frequency of discomfort (76%) was reported by
participants with the oral fluid test. With the finger-stick test,
63% reported no discomfort, while, with venous blood draw,
discomfort was reported by 94% participants.
Other issues with finger-stick test were pain reported by
26% participants, fear of giving blood by 11% participants.
With venous blood draw, 20% participants reported pain,
62% reported fear of giving blood, and 18% pain and
swelling.
Feasibility of Counseling in the Labor Room Setting
Anecdotally, based on the reports of the counselors, the
postpartum counseling session was well received by the study
participants. According to the counselors, women were
relaxed and were better able to question and comprehend
information provided on care of their infant, including
information on HIV transmission through breast milk.
Disclosure of Test Results
Counselors had strict instructions to protect the confiden-
tiality of test results. A majority (85%) of women preferred to
know their results right after testing. Disclosure of results to
the spouses was left to the discretion of the study partic-
ipants. We do not have information on how many HIV-
negative women disclosed their serostatus to their partner.
We do have information on HIV-positive women. Of all HIV-
positive women, 75% (12/15) discussed their serostatus with
their husbands and the remainder (3/15) with their mothers.
Discussion
HIV testing of pregnant women during labor and delivery
is one of the last opportunities to prevent mother-to-child
HIV transmission, especially in women who do not have
access to antenatal care and HIV testing services early in
pregnancy. In India, a sizeable proportion of rural women
present to hospitals for delivery without any prior antenatal
care [10,11]. Even those women who do receive some
antenatal care do not always get tested for HIV for various
reasons.
In this study, we assessed the impact of introducing round-
the-clock, rapid, point-of-care HIV counseling and testing in
a labor ward in rural India. Our results show that it is feasible
to introduce a program of round-the-clock oral rapid HIV
testing, including abbreviated prepartum and extended
postpartum counseling sessions, even in a very busy labor
room setting in an Indian village. In our study, all women who
consented were successfully counseled and tested. Counseling
in the labor room setting was highly feasible, even in a busy
rural hospital setting. Our data suggest that the availability of
round-the-clock rapid HIV testing resulted in successful
documentation of HIV serostatus in a large proportion of
women who were unaware of their HIV status when admitted
to the labor ward. In addition, 11 of a total of 15 HIV-positive
women received PMTCT interventions because they under-
went rapid testing in the labor ward. Lastly, with regard to
rapid test accuracy, both oral and finger-stick OraQuick tests
had excellent specificity (100%), with one false negative
result.
An important finding of our study was that of the 564
Table 2. Diagnostic Accuracy of OraQuick Oral Fluid Test
OraQuick Oral
Test Results
EIA þ Western
Blot Positive
EIA
Negative
Total
Positive 14 0 14
Negative 1 1,207 1,208
Total 15 1,207 1,222
Sensitivity¼ 93.3% (95% CI 71.3%–99.7%)
Specificity¼ 100% (95% CI 99.75%–100%)
Positive predictive value¼ 100% (95% CI 99.99%–100.0%)
Negative predictive value¼ 99.96% (95% CI 99.6%–99.98%)
Kappa¼ 1.00 (95% CI 0.99–1.00)
doi:10.1371/journal.pmed.0050092.t002
Table 3. Diagnostic Accuracy of OraQuick Finger-stick Test
OraQuick Finger-Stick
Test Results
EIA þ Western
Blot Positive
EIA
Negative
Total
Positive 14 0 14
Negative 1 1,207 1,208
Total 15 1,207 1,222
Sensitivity¼ 93.3% (95% CI 71.3%–99.7%)
Specificity¼ 100% (95% CI 99.75%–100%)
Positive predictive value¼ 100% (95% CI 99.99%–100.0%)
Negative predictive value¼ 99.96% (95% CI 99.6%–99.98%)
Kappa¼ 1.00 (95% CI 0.99–1.00)
doi:10.1371/journal.pmed.0050092.t003
PLoS Medicine | www.plosmedicine.org May 2008 | Volume 5 | Issue 5 | e920773
Rapid HIV Testing of Women in Labor
women who claimed to have been tested for HIV some time
during pregnancy, only 219 were confident in reporting test
results. A majority of the women had failed to pick up their
test results from private providers or had not been
adequately informed about test results. Of the 15 HIV-
positive women, only four reported having been tested in
pregnancy. In our study, a majority of women sought HIV
testing from private practitioners (including unlicensed
providers) and were unaware of the test results. These data
suggest that there are several missed opportunities for HIV
testing during pregnancy.
In India, HIV testing is not routinely offered by health care
providers, especially in the private health care sector [18].
Further, several factors acting at individual, community,
regional, and national levels prevent women from seeking
voluntary HIV testing in pregnancy. Individual-level factors
include poverty and difficulty in accessing health care,
reluctance of rural women to seek hospital care as opposed
to midwife-based home care, stigma, fear of obtaining a
positive test result coupled with the fear of intimate partner
violence and ostracism by the partner’s family, and lack of
awareness about the effectiveness of PMTCT interventions
[18]. Community-level factors include stigma, discrimination
by community and health care professionals, and lack of
social support [18,19]. Regional- and national-level factors
are: (1) lack of infrastructure (including availability of round-
the-clock laboratory technicians); (2) irregular and insuffi-
cient supply of HIV rapid test kits; (3) cumbersome and time-
consuming blood-based rapid tests; (4) lack of 24-h round-
the-clock counseling services; and (5) women presenting late
in labor (often within obstetric complications), which makes
it difficult for obstetricians to arrange for urgent PMTCT
interventions [4,10]. In our study, by offering round-the-clock
rapid testing and two-stage counseling, we were able to
deliver PMTCT interventions to women who presented late in
labor with no prior history of HIV testing and/or antenatal
care.
Acceptability of rapid testing in our study was 98%, as
compared to 83%–85% reported elsewhere [20–22]. Prefer-
ence for oral fluid–based tests over blood-based tests was
70%. This preference could be because oral fluid testing was
convenient and did not elicit patients’ fear of blood draw, or
pain of needle stick and venipuncture. Our previous study in
sexually transmitted disease clinic attendees in India docu-
mented a similarly high preference for the oral fluid–based
rapid tests [4].
Effective counseling sessions can play a major role in the
institution of PMTCT interventions worldwide. However,
counseling women in labor is a challenging endeavor [11,12].
Besides, issues such as patient confidentiality, privacy of
disclosure, and social support for the care of infant and
mother all affect the emotional health of both mother and
baby and need to be addressed [12,20]. In our study, an
abbreviated counseling session during labor and an extended
postpartum counseling session led to a better uptake of
advice from counselors in comparison to a one stage
counseling session in labor used previously in routine
practice settings [6,11,12].
To our knowledge, our study is the first and largest study in
a rural setting in the world, introducing round-the-clock
rapid HIV testing and counseling in pregnant women in
labor. The novel features of our study are: (1) use of an oral
fluid–based OraQuick Rapid HIV-1/HIV-2 test; (2) use of a
parallel testing strategy with finger-stick OraQuick Rapid
HIV-1/HIV-2 test; (3) round-the-clock availability of trained
counselors, and use of a two-stage (i.e., abbreviated prepar-
tum and extended postpartum) counseling sessions; (4)
evaluation of this strategy in a rural population in a resource
constrained setting.
In previous studies, blood-based rapid HIV tests have been
used in pregnant women in both antenatal clinics and labor
rooms [6,21,23,24]. The US Centers for Disease Control and
Prevention (CDC)–funded Mother Infant Rapid Intervention
at Delivery (MIRIAD) study evaluated the feasibility and
performance of the blood-based rapid OraQuick Rapid HIV
test in 4,849 pregnant women in labor across 16 hospitals in
the US [21]. Of 7,381 potential participants, 4,849 women
consented (84%) for testing [21]. In comparison, our consent
rate was 98%.
Three studies have been conducted in pregnant women in
antenatal clinics and delivery rooms in urban India [10,11,20].
In the first study, 1,258 consenting women were tested with
blood-based rapid HIV and salivary brush OraQuick HIV
tests. A lower sensitivity of 75% for OraQuick saliva test was
detected due to inadequate salivary sample collection and use
of inferior quality gold standard ELISA test [10]. In our study,
an advanced version of oral fluid–based OraQuick Rapid
HIV-1/HIV-2 in a parallel strategy with a reference standard
of dual ELISA and Western blot improved our estimates of
diagnostic accuracy. In the second Indian study, about 522 of
1,322 women (44%) consented to test with four rapid HIV
tests (i.e., three rapid finger-stick and one rapid saliva test).
Approximately, 61% women presented with a prior history of
HIV testing, and four new cases of HIV were identified [11].
In our study, a majority (82%) of women presented with no
history of HIV testing, and eleven new cases were identified.
In the third study, 61% (417 of 613) women accepted testing
and counseling, as compared to 98% in our study [20]. The
higher acceptance rate in our study could be attributed to the
use of an oral fluid HIV test and a two-stage counseling
session that were not employed in earlier studies [20].
Our study has strengths and limitations. Strengths include
a fairly large sample size, a high response rate, inclusion of
several rural women with no prior antenatal care, and
provision of round-the-clock two-stage counseling and
point-of-care oral rapid HIV testing services even in a busy
rural labor room setting.
With regard to limitations, our study was not designed to
detect HIV seroprevalence in all pregnant women. Further,
our sensitivity estimates of OraQuick tests were imprecise
because of the relatively few HIV-positive women diagnosed
during the study period. Our study was conducted in a rural,
labor ward setting in India, and therefore our results may not
be generalizable to all settings. Due to the fact that we utilized
the existing hospital resources and rapid HIV test kits
donated to us for the study, we were unable to precisely
assess the total costs involved in setting and implementing
our testing and counseling program. We are currently
planning cost-effectiveness and cost-benefit analyses of
introducing a round-the-clock rapid HIV testing program
in the labor ward. Lastly, while we have demonstrated the
feasibility and impact of introducing a round-the-clock rapid
HIV testing program in the labor ward, the sustainability of
such projects and their evaluation for implementation at the
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country level will require involvement of government and
international agencies.
Conclusions
In a busy, rural labor ward setting in India, we demon-
strated the feasibility and impact of introduction of a round-
the-clock rapid HIV testing and two-stage counseling
program. Our data suggest that this testing approach resulted
in successful documentation of HIV serostatus in a large
proportion of women who were unaware of their HIV status
when admitted to the labor ward. Additionally, a high
proportion of HIV-positive women received PMTCT inter-
ventions due to rapid testing in labor. These findings may
inform existing PMTCT programs in similar settings world-
wide to upgrade the current testing services in rural resource
constrained settings. This includes incorporation of patient
preferred oral rapid point-of-care HIV tests and patient-
tailored two-stage counseling sessions that worked well in our
setting. Such targeted initiatives may also help estimate
burden of HIV infection in pregnant women with unknown
serostatus in similar settings worldwide.
Supporting Information
Figure S1. HIV Testing Algorithm
Found at doi:10.1371/journal.pmed.0050092.sg001 (33 KB DOC).
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Editors’ Summary
Background. Since the first reported case of AIDS (acquired immuno-
deficiency syndrome) in 1981, the number of people infected with the
human immunodeficiency virus (HIV), which causes AIDS, has risen
steadily. Now, more than 33 million people are infected, almost half of
them women. HIV is most often spread through unprotected sex with an
infected partner, but mother-to-child transmission (MTCT) of HIV is also
an important transmission route. HIV-positive women often pass the
virus to their babies during pregnancy, labor and delivery, and
breastfeeding, if nothing is done to prevent viral transmission. In
developed countries, interventions such as voluntary testing and
counseling, safe delivery practices (for example, offering cesarean
delivery to HIV-positive women), and antiretroviral treatment of the
mother during pregnancy and labor and of her newborn baby have
minimized the risk of MTCT. In developing countries, the prevention of
MTCT (PMTCT) is much less effective, in part because pregnant women
often do not know their HIV status. Consequently, in 2007, nearly half a
million children became infected with HIV mainly through MTCT.
Why Was This Study Done? In many developing countries, women do
not receive adequate antenatal care. In India, for example, nearly half the
women living in rural areas do not receive any antenatal care until they
are in labor. This gives health care providers very little time in which to
counsel women about HIV infection, test them for the virus, and start
interventions to prevent MTCT. Furthermore, testing pregnant women in
labor for HIV and counseling them is a challenge, particularly where
resources are limited. In this study, therefore, the researchers investigate
the feasibility and impact of introducing round-the-clock, rapid HIV
testing and counseling in a busy labor ward in a rural teaching hospital in
Sevagram, India.
What Did the Researchers Do and Find? Women admitted to the labor
ward between January and September 2006 were offered two rapid HIV
tests—one that used a saliva sample and the other that used blood
taken from a finger prick. Blood was also taken from a vein for
conventional HIV testing. All the women were given a 15-minute
counseling session about how HIV is transmitted, the importance of HIV
testing, and information on PMTCT before their child was born
(prepartum counseling), and a longer postpartum counseling session.
HIV-positive women were given a cesarean delivery where possible and
antiretroviral drug treatment to reduce MTCT. 1,222 women admitted to
the labor ward during the study period (1,003 of whom did not know
their HIV status) accepted HIV testing. Of 15 study participants who were
HIV positive, 11 learnt of their HIV status in the labor room. Two babies
born to these HIV-positive women were HIV positive and died within a
month of delivery; the other 13 babies were HIV negative at birth and at
1 and 4 months after delivery. Finally, the rapid HIV tests missed only one
HIV-positive woman (no false-positive results were given), and the time
from enrolling a woman into the study through referring her for PMTCT
intervention where necessary averaged 40–60 minutes.
What Do These Findings Mean? These findings show the feasibility and
positive impact of the introduction of round-the-clock pre- and
postpartum HIV counseling and rapid HIV testing into a busy rural
Indian labor ward. Few of the women entering this ward knew their HIV
status previously but the introduction of these facilities in this setting
successfully informed these women of their HIV status. In addition, the
round-the-clock counseling and testing led to 11 women and their
babies receiving PMTCT interventions who would otherwise have been
missed. These findings need to be confirmed in other settings and the
cost-effectiveness and sustainability of this approach for the improve-
ment of PMTCT in developing countries needs to be investigated.
Nevertheless, these findings suggest that round-the-clock rapid HIV
testing might be an effective and acceptable way to reduce MTCT of HIV
in many developing countries.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0050092.
 Read a related PLoS Medicine Perspective article
 Information is available from the US National Institute of Allergy and
Infectious Diseases on HIV infection and AIDS and on HIV infection in
women
 HIV InSite has comprehensive information on all aspects of HIV/AIDS
 Women, Children, and HIV provides extensive information on the
prevention of mother-to-child transmission of HIV in developing
countries
 Information is available from Avert, an international AIDS charity, on
HIV and AIDS in India, on women, HIV, and AIDS, and on HIV and AIDS
prevention, including the prevention of mother-to-child transmission
 AIDSinfo, a service of the US Department of Health and Human
Services provides health information for HIV-positive pregnant women
(in English and Spanish)
PLoS Medicine | www.plosmedicine.org May 2008 | Volume 5 | Issue 5 | e920776
Rapid HIV Testing of Women in Labor
